ABSTRACT
We found that eight of 22 patients with meningeal carcinomatosis from different primary tumors produced local IgG in the CSF, as indicated by elevated IgG index and/or oligoclonal IgG subfractions. Local IgG production, when present, appears in an early stage of the leptomeningeal manifestation and remains detectable over extended observation periods. In autopsied cases with local IgG production, we observed numerous perivascular round-cell infiltrates containing plasma cells and large lymphocytes within the leptomeningeal tumor tissue. After incubation with immunoperoxidase, only these cells showed IgG-specific staining, indicating the site of local IgG production.
Subject(s)
Carcinoma/cerebrospinal fluid , Immunoglobulin G/cerebrospinal fluid , Meningeal Neoplasms/cerebrospinal fluid , Adult , Aged , Carcinoma/pathology , Carcinoma/secondary , Female , Humans , Immunoglobulins/cerebrospinal fluid , Male , Meningeal Neoplasms/pathology , Meningeal Neoplasms/secondary , Middle Aged , Oligoclonal BandsABSTRACT
A specific, sensitive, and reliable sandwich-ELISA (enzyme-linked immunosorbent assay) has been established for the determination of choline acetyltransferase (CHAT) from porcine brain. The detection limit of the assay was 30 micrograms/l and the assay was linear up to 300 micrograms/l. The within-day and day-to-day coefficients of variation were found to be 3.3% and 4.7% respectively for low CHAT concentrations (30 micrograms/l) and 3.1% and 3.4% respectively for high levels of CHAT (300 micrograms/l). The immunoassay was more sensitive than the radiometric assay of Fonnum which is widely used for the measurement of enzyme activity. In the assay monoclonal antibody was adsorbed to the polystyrene surface of the immunoplate as the capture reagent. Using a standard peroxidase protocol the immobilized antigen was detected with a highly specific anti-CHAT antiserum raised in rabbits. Two monoclonal antibodies were available for antigen binding. One of the two--A10.29B4--reacted preferentially with the active enzyme the other one--B3.9B3--reacted only with a degraded form. The polyclonal antiserum recognized both native and denatured enzyme. The effectiveness of employing the two monoclonal antibodies separately or in combination was demonstrated by measurement of porcine CHAT diluted in human cerebrospinal fluid and serum. After some minor modifications the sandwich-ELISA could be used for the determination of CHAT from the central nervous system of the rat.
Subject(s)
Choline O-Acetyltransferase/analysis , Enzyme-Linked Immunosorbent Assay/methods , Animals , Antibodies, Monoclonal/immunology , Choline O-Acetyltransferase/immunology , Goats , Rabbits , SwineABSTRACT
An ELISA procedure is described for the quantification of intrathecally synthesized immunoglobulin G antibodies to human immunodeficiency virus (HIV) antigens. Recombinant p17, p24, endonuclease (END), reverse transcriptase (RT), a peptide from the transmembrane region of gp41 (ENV80) and a fusion protein containing HIV-1 and HIV-2 epitopes were compared with a commercially available ELISA. Using a reference serum, antibodies in serum and cerebrospinal fluid (CSF) to all of the antigens could be measured quantitatively in a reliable and reproducible fashion. Despite the fact that the titer varied up to 10(5)-fold between CSF and serum, interassay variability ranged from 3.87% for p17 to 8.41% for RT and intra-assay variability varied from 3.9% +/- 1.2% for p17 to 14.3% +/- 3.9% for the commercial ELISA. Antibody specificity indices (ASI) obtained by relating CSF/serum titers with reference to the corresponding IgG concentrations can be used to detect intrathecal synthesis of virus specific antibodies.
Subject(s)
HIV Antibodies/analysis , HIV Antigens/immunology , HIV-1/immunology , Spinal Cord/immunology , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin G/cerebrospinal fluid , Recombinant Proteins/immunologyABSTRACT
Various human secretions (intestinal secretion, saliva, nasal mucus, lacrimal fluid) have been found to inhibit the binding of antibodies to their antigens. Various characteristics (e.g. time, pH, temperature dependence, affinity and size exclusion chromatography) suggested that the inhibitory activity was attributable to an enzyme. Further investigations revealed that this enzyme reacted with the Fab portion of immunoglobulin G, specifically with the heavy chain. It is assumed that it represents a novel immunoglobulin-specific protease since similar results were not obtained with proteolytic enzymes from human digestive organs e.g. pepsin, trypsin and chymotrypsin. Finally, investigating saliva it was demonstrated that the putative protease was not identical to enzymes from periodontal bacteria which are proteolytic for the Fc portion of immunoglobulins. The findings could be of general importance in the design of immunoassays which are to be applied to human (and possibly animal) secretions.
Subject(s)
Antigen-Antibody Reactions/drug effects , Endopeptidases/metabolism , Endopeptidases/pharmacology , Saliva/enzymology , Saliva/metabolism , Alkaline Phosphatase/antagonists & inhibitors , Animals , Cattle , Humans , Immunoassay , Immunoglobulin Fab Fragments/chemistry , Immunoglobulin G/chemistry , Immunoglobulin G/pharmacology , Isoelectric Focusing , Saliva/immunologyABSTRACT
Two-site enzyme-linked immunosorbent assays (ELISA) have been established for the specific and sensitive determination of two membrane proteins of the small synaptic vesicles (SSV), namely: peripheral synapsin I and integral synaptophysin. The ELISA used highly specific capture monoclonal antibodies (mAB) and polyclonal antibodies (pAB) as detectors. For synapsin I, the mAB were newly generated, whereas for synaptophysin, the commercially available mAB SY38 was applied. In order to calibrate the ELISA and to raise pAB, both proteins were purified in the mg-range. Synapsin I was purified by conventional means from human and porcine brain and synaptophysin was purified by immunoaffinity chromatography from porcine brain. Using the ELISA, neither synapsin I nor synaptophysin could be determined in serum or cerebrospinal fluid (CSF) from healthy donors or patients suffering various neurological disorders or pheochromocytomas. For this reason, the degradation of both proteins in serum and CSF was investigated. With the exception of synaptophysin measured in serum, both proteins exhibited fast rates of degradation. Despite the negative results in human body fluids, the two ELISA are appropriate for the quantification of these membrane proteins in neuronal or neuroendocrine cell extracts or preparations of SSV.
Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Synapsins/blood , Synapsins/cerebrospinal fluid , Synaptophysin/blood , Synaptophysin/cerebrospinal fluid , Amino Acid Sequence , Animals , Antibodies , Antibodies, Monoclonal , Brain Chemistry , Calibration , Chromatography, Affinity , Humans , Mice , Molecular Sequence Data , Sensitivity and Specificity , Swine , Synapsins/isolation & purification , Synaptophysin/isolation & purificationABSTRACT
A newly developed peroxidase-linked immunoassay is described which is sensitive enough to quantify herpes simplex antibodies in serum and cerebrospinal fluid diluted to an IgG level of 1 mg/dl. Thus, a comparison of photometric signals allows the direct detection of specific antibodies which have been secreted by activated tissue B lymphocytes into the CSF compartment during the humoral immune phase of herpes simplex encephalitis. The technique utilizes urea-Triton-dissolved virus antigens covalently bound to Sepharose 4B pearls. A highly specific sandwich antibody was purified by immune absorption column chromatography and labelled in its protected state. In the majority of cases the antibody level increased around the 10th day, to reach its maximum a few days after. In some cases however the serum levels gradually rose over a period of several weeks. The antibody levels in the CSF increase uniformly at the same time, irrespective of the general immune response and soared up to higher than serum levels within a few days. Local antibody production may persist for years so that late diagnosis of herpes encephalitis becomes possible with a single side by side test of serum and CSF from the patient.
Subject(s)
Antibodies, Viral/cerebrospinal fluid , Encephalitis, Arbovirus/diagnosis , Herpes Simplex/complications , Immunoglobulin G/cerebrospinal fluid , Acute Disease , Animals , Antibodies, Viral/biosynthesis , Brain/microbiology , Chronic Disease , Complement Fixation Tests , Encephalitis, Arbovirus/etiology , Encephalitis, Arbovirus/immunology , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin G/biosynthesis , Meningoencephalitis/diagnosis , Meningoencephalitis/immunology , Multiple Sclerosis/diagnosis , Multiple Sclerosis/immunology , Rabbits , SepharoseABSTRACT
Applying the immunoblot technique a sensitive and specific method was developed for the detection of intrathecally synthesized antibodies against individual specific proteins that are antigens of various infectious agents causing encephalitis. Paired serum and cerebrospinal fluid (CSF) samples from five patients with herpes virus infections of the central nervous system (CNS) (three herpes simplex virus encephalitis, one varicella zoster virus encephalitis, one zoster ganglionitis) were investigated for the presence of locally produced IgG against the electrophoretically separated antigens of herpes simplex virus (HSV), varicella zoster virus (VZV) and human cytomegalovirus (HCMV), as well as for IgM antibodies in one case of HSV encephalitis. In two cases (HSV encephalitis and VZV encephalitis) four and one antibody, respectively, were found that were synthesized intrathecally only. In the other cases the patterns of sera and CSF antibodies were similar, the CSF antibodies showing an all-over stronger reaction, at identical IgG concentrations. In contrast to the conception of a 'limited heterogeneity' of intrathecal antibody synthesis in encephalitis, we thus found an 'expanded heterogeneity' of the intrathecally synthesized antibodies in comparison to the corresponding serum antibodies.
Subject(s)
Antibodies, Viral/immunology , Central Nervous System Diseases/immunology , Herpesviridae Infections/immunology , Adult , Aged , Antibody Specificity , Antigens, Viral/immunology , Central Nervous System Diseases/blood , Central Nervous System Diseases/cerebrospinal fluid , Cytomegalovirus/immunology , Female , Herpesviridae Infections/blood , Herpesviridae Infections/cerebrospinal fluid , Herpesvirus 3, Human/immunology , Humans , Immunoblotting/methods , Male , Middle Aged , Simplexvirus/immunologyABSTRACT
Intrathecally produced antibodies specific for the infectious agent can be shown by immunoblot. A quantification is practicable by titration. Densitometric evaluation of the immunoblot by a new technique, IDEA (immunoblot for densitometric estimation of antibodies), does not only render titration unnecessary, but also has the advantage of presenting the differentiated local immune response against individual antigens of the infectious agent. Preliminary studies for the densitometric evaluation were performed with a measles virus immunoblot which had been developed with a cerebrospinal fluid (CSF) sample of a patient suffering from multiple sclerosis containing high antibody titers. A peroxidase-labeled anti-immunoglobulin antibody had been added. The intensity of the color reaction on the membrane dependent on the antibody concentration follows a saturation kinetics comparable to the Michaelis-Menten kinetics in enzymology. Thus, indices for the intrathecal antibody synthesis of each individual viral antigen can be calculated by taking the permeability of the blood-CSF barrier into consideration. This method is illustrated in a patient with zoster meningoencephalitis.
Subject(s)
Antibodies, Viral/analysis , Central Nervous System Diseases/immunology , Virus Diseases/immunology , Antigens, Viral/immunology , Densitometry , Humans , Immunoblotting , Immunoglobulin G/analysis , Measles virus/immunologyABSTRACT
A specific and sensitive two-side enzyme-linked immunosorbent assay (sandwich-ELISA) was established for the reliable quantification of human brain and placental choline acetyltransferase (ChAT). In contrast to the radiometric assay developed by Fonnum, which is widely used for the measurement of enzyme activity, the sandwich-ELISA particularly recognized inactivated forms of the antigen. In the assay, affinity-purified polyclonal synthetic peptide antibodies adsorbed to the polystyrene surface of the microtiter plate were employed as capture reagent. Based on standard peroxidase protocols, immobilized ChAT was detected using monoclonal antibodies raised against human placental ChAT. By use of this ELISA, ChAT was determined at various purification stages of the enzyme, in body fluids, during recovery experiments and in sera of patients with severe brain damage.
Subject(s)
Choline O-Acetyltransferase/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Amino Acid Sequence , Animals , Choline O-Acetyltransferase/isolation & purification , Choline O-Acetyltransferase/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Mice , Middle Aged , Molecular Sequence DataABSTRACT
Six patients with herpes simplex encephalitis were investigated. Antibody activities against different viral antigens were determined in serum and cerebrospinal fluid with an enzyme-linked immunosorbent assay after adjusting both fluids to identical immunoglobulin G concentrations. In serum, the strength of the antiviral reaction remained low and no qualitative changes became detectable. In cerebrospinal fluid, at first locally synthesized antibodies were directed against the same antigens as in serum. Ten days later, the intrathecal reaction increased with additional antibodies against at least two antigens. Once established, this expanded heterogeneity remained stable during the course of the disease.
Subject(s)
Encephalitis/etiology , Herpes Simplex , Antibodies, Viral/analysis , Antibodies, Viral/cerebrospinal fluid , Antigens, Viral/analysis , Antigens, Viral/cerebrospinal fluid , Electrophoresis, Polyacrylamide Gel , Encephalitis/blood , Encephalitis/immunology , HumansABSTRACT
A two-sided enzyme-linked immunosorbent assay (ELISA) has been established for reliable, specific and sensitive determination of synaptophysin (SYN), an intrinsic membrane protein of the small synaptic vesicles. This ELISA used a highly specific monoclonal antibody (SY 38) as capture reagent and a specific SYN antiserum in combination with a secondary peroxidase-conjugated antibody for detection. Calibration was carried out with immunoaffinity-purified SYN from porcine cortex. The sensitivity was found to be improved substantially when the ELISA was compared with previously used dot-immunobinding assays. This ELISA allowed rapid and reliable determination of SYN from detergent lysed homogenates, partially and highly purified preparations of rat, porcine and human brain. SYN was determined in highly purified small synaptic vesicles, and it was calculated to be 5.8% of total detergent solubilized protein.
Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Synaptophysin/analysis , Animals , Blotting, Western , Humans , Immunoblotting , Microscopy, Electron , Rabbits , Rats , Rats, Inbred Lew , Swine , Synaptic Vesicles/chemistry , Synaptic Vesicles/ultrastructure , Synaptophysin/isolation & purificationABSTRACT
OKT8-binding lymphocytes, which consist mainly of suppressor-cytotoxic T cells, were demonstrated in blood and CSF by an immunochemical method. In patients with non-inflammatory diseases, the mean value was 18% in blood and 19% in CSF. In acute viral infections of the CNS, on the other hand, the percentage was significantly lower in the initial days of the disease but then increased up to the 5th week. Eleven patients suffering from multiple sclerosis had similar percentages of OKT8-binding cells, whether or not they had acute symptoms.
Subject(s)
Nervous System Diseases/immunology , T-Lymphocytes/immunology , Central Nervous System Diseases/immunology , Humans , Multiple Sclerosis/immunology , T-Lymphocytes/analysis , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Regulatory/immunology , Virus Diseases/immunologyABSTRACT
A soluble form of the intercellular adhesion molecule-1 (sICAM-1) was measured in paired cerebrospinal fluid (CSF)/blood samples from 123 patients with different neurological diseases. Mean levels of circulating ICAM-1 in the blood were mean +/- SD = 423 +/- 184.6 ng ml-1 (range 44-1115 ng ml-1). Considerable differences of sICAM-1 in the CSF of patients were observed between disease groups. In acute bacterial meningitis, sICAM-1 levels as high as 1/5 of the serum concentration were detected in the CSF (n = 24; mean +/- SD = 33.0 +/- 23.7 ng ml-1; range: 4.8-93.9 ng ml-1). These changes coincided with a severe blood-CSF barrier dysfunction as indicated by a high CSF/blood ratio for albumin (mean +/- SD = 46.7 +/- 52.2; range: 16.8-249.3). In patients with polyradiculitis (n = 9; mean +/- SD = 14.5 +/- 11.9 ng ml-1; range: 2.6-43.7 ng ml-1) a similar covariation between the albumin and sICAM CSF/blood ratios was detected. In patients with multiple sclerosis (n = 9; mean +/- SD = 5 +/- 4.3; range: 0-12.7 ng ml-1) or HIV infection with neurological symptoms (n = 18; mean +/- SD = 4.9 +/- 3.2; range; 1-11.9 ng ml-1) low levels of sICAM-1 were detected in the CSF associated with intact blood-CSF barrier function in most patients. Among 13 patients with viral meningitis, only four had detectable levels of sICAM-1 in their CSF (mean +/- SD = 1.0 +/- 1.5 ng ml-1; range: 0-3.7).(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Blood-Brain Barrier , Cell Adhesion Molecules/cerebrospinal fluid , Neuritis/cerebrospinal fluid , Antigens, CD/cerebrospinal fluid , Base Sequence , Cell Adhesion , Gene Expression , Humans , Intercellular Adhesion Molecule-1 , Molecular Sequence Data , Neuritis/diagnosis , Neuritis/pathology , Oligodeoxyribonucleotides/chemistry , Prognosis , RNA, Messenger/genetics , Tumor Necrosis Factor-alpha/geneticsABSTRACT
Transmigration of human granulocytes across a basal lamina equivalent was studied in vitro. Transwell inserts were coated with Matrigel, a reconstituted basement membrane. Granulocytes (2x10(6)) were applied to the upper chamber. As chemoattractant interleukin-8 (IL-8; 25 ng/ml) was added to the lower chamber. After 1 h of migration, cells were counted in the lower chamber. Specific hydroxamate inhibitors of MMPs (BB-3103, Ro 31-9790) or of serine proteases (Pefabloc, leupeptin) were added at various concentrations to both chambers before the start of migration. Additional experiments were performed with alpha(2)-macroglobulin, a natural inhibitor of MMPs and a monoclonal antibody which specifically blocks the activity of MMP-9. Migration of granulocytes through Matrigel could not be reduced significantly by any of the MMP inhibitors. A dose-dependent impairment of transmigration was only found with Pefabloc, however, this substance also induced severe morphological changes of the cells. The other inhibitor of serine proteases, leupeptin, did not influence migration at all.
Subject(s)
Basement Membrane/physiology , Granulocytes/physiology , Matrix Metalloproteinase 9/physiology , Cell Movement/drug effects , Cells, Cultured , Chemotactic Factors/pharmacology , Collagen/pharmacology , Drug Combinations , Enzyme Inhibitors/pharmacology , Humans , Hydroxamic Acids/pharmacology , Interleukin-8/pharmacology , Laminin/pharmacology , Matrix Metalloproteinase Inhibitors , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Proteoglycans/pharmacology , Serine Proteinase Inhibitors/pharmacology , alpha-Macroglobulins/pharmacologyABSTRACT
Although multiple sclerosis (MS) is considered primarily as a demyelinating disease, neuronal damage is abundant and correlates with the neurological deficit. Therefore, we investigated the frequency and characteristics of human T cells specific for synapsin-a neuronal protein highly conserved among species. Synapsin specific T cell responses were detected at a frequency similar to that of MBP specific T cells in MS patients, one patient with acute demyelinating encephalomyelitis (ADEM) and controls. Long-term T cell lines specific for synapsin exhibited a CD3(+), CD4(+), CD8(-) phenotype and produced high amounts of tumor-necrosis-factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) after antigen specific stimulation, whereas lymphotoxin (LT), interleukin-4 (IL-4) and interleukin-10 (IL-10) were detectable in smaller quantities.
Subject(s)
Multiple Sclerosis/immunology , Synapsins/immunology , T-Lymphocytes/immunology , Acute Disease , CD3 Complex/biosynthesis , CD4 Antigens/biosynthesis , Cell Line , Dose-Response Relationship, Immunologic , Encephalomyelitis, Acute Disseminated/immunology , Humans , Immunophenotyping , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , Interleukin-4/biosynthesis , Lymphotoxin-alpha/biosynthesis , Myelin Basic Protein/immunology , T-Lymphocytes/cytology , Tumor Necrosis Factor-alpha/biosynthesisABSTRACT
Matrix metalloproteinase-9 (MMP-9) was investigated by enzyme-linked immunosorbent assay (ELISA) and zymography in 111 paired CSF and serum samples from patients with various neurological disorders. In 20 patients with blood-brain barrier (BBB) impairment but normal CSF cell count, elevated levels of MMP-9 were not observed by ELISA measurement. Another 11 patients characterized in the same way, exhibited only slightly increased MMP-9 levels. In contrast, in 12 patients with intact BBB but elevated CSF cell count, MMP-9 was increased too. It was shown by the more sensitive zymography that MMP-9 increased if CSF cell count exceeded five cells per microl. Spearman rank statistics revealed that MMP-9 concentration in CSF correlated with CSF cell count (r=0.755; P<0.0001), but not with CSF/serum albumin ratio (Q(Alb)) (r=0.212; P=0.057), a measure for BBB impairment. Moreover, the CSF/serum MMP-9 ratio (Q(MMP-9)) did not correlate with Q(Alb)(r=0.192; P=0.100). By use of a Boyden chamber, in which granulocytes migrated through a reconstituted basement membrane, it was demonstrated that the MMP-9 concentration in the lower chamber correlated very significantly with the number of accumulated cells (r(2)=0.7692; P<0.0001). The meaning of the increase of MMP-9 in CSF is critically discussed.
Subject(s)
Blood-Brain Barrier/immunology , Matrix Metalloproteinase 9/cerebrospinal fluid , Nervous System Diseases/immunology , Nervous System Diseases/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Amyotrophic Lateral Sclerosis/immunology , Amyotrophic Lateral Sclerosis/metabolism , Cerebrospinal Fluid/cytology , Cerebrospinal Fluid/enzymology , Chemotaxis, Leukocyte/immunology , Child , Female , Granulocytes/cytology , Granulocytes/immunology , Guillain-Barre Syndrome/immunology , Guillain-Barre Syndrome/metabolism , Humans , Lyme Neuroborreliosis/immunology , Lyme Neuroborreliosis/metabolism , Male , Matrix Metalloproteinase 1/blood , Matrix Metalloproteinase 1/cerebrospinal fluid , Matrix Metalloproteinase 9/blood , Meningitis, Bacterial/immunology , Meningitis, Bacterial/metabolism , Meningitis, Viral/immunology , Meningitis, Viral/metabolism , Middle Aged , Multiple Sclerosis/immunology , Multiple Sclerosis/metabolismABSTRACT
Determination of matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF) to study blood-brain barrier impairment and immune cell migration in inflammatory neurological diseases recently became a matter of major interest. Regularly, MMP-9 was determined qualitatively or semi-quantitatively by zymography (gelatin gel electrophoresis) or quantitatively by enzyme immunoassay (EIA). As yet, it was not possible by either method to detect MMP-9 in CSF of controls (patients without pathologically increased CSF parameters). We developed an ultrasensitive two-side enzyme-linked immunosorbent assay (ELISA) which allows for the first time to measure reliably MMP-9 concentrations in CSF of controls. This ELISA uses a monoclonal as capture and a polyclonal as detector antibody. The detection limit of the assay is below 10 pg/ml and the assay range is 15-2000 pg/ml. Intra-assay precision is 2.5% for low and 3.7% for high, inter-assay precision is 11% for low and 10.7% for high values, respectively. The determination of the MMP-9 concentration in 50 control CSF gave the following results: range, 22-146 pg/ml; median, 76 pg/ml. The measurement of native and recombinant MMP-9 was carried out with three commercially available ELISAs, most widely employed in MMP-9 research, and compared to the newly developed one. All ELISAs recognize recombinant MMP-9 by factors of 5-20 less sensitively than native MMP-9.
Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Matrix Metalloproteinase 9/cerebrospinal fluid , Adult , Aged , Aged, 80 and over , Enzyme-Linked Immunosorbent Assay/standards , Female , Humans , Male , Matrix Metalloproteinase 9/analysis , Middle Aged , Reference Values , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
Serum levels of circulating ICAM-1 are increased in various disorders including inflammatory diseases of the central nervous system (CNS). We recently described an association between high sICAM-1 levels in the serum of patients with multiple sclerosis and disease activity. The functional consequences of increased circulating adhesion molecules are not fully understood. This may simply arise as a consequence of inflammation or may have immune modulating properties. ICAM-1 plays an important role in the recruitment of activated lymphocytes to sites of inflammation within the CNS. We therefore tested the ability of soluble forms of ICAM-1 to prevent adhesion of activated lymphocytes to cerebral endothelial cells. Mitogen-activated blood mononuclear cells (PBMC) as well as PBMCs from patients with active multiple sclerosis adhered to cerebral endothelial cell cultures in vitro. This adhesion could be blocked if lymphocytes were preincubated with a recombinant form of soluble ICAM-1. In addition, serum from patients with active multiple sclerosis and high sICAM-1 levels blocked adhesion in a dose-dependent manner which was abrogated by pre-adsorption to an anti ICAM-1 antibody. Since soluble forms of ICAM-1 are able to block lymphocyte adhesion to cerebral endothelial cells, they may provide new therapeutic tools to interfere with the pathogenesis of inflammatory diseases of the CNS.
Subject(s)
Cerebrovascular Circulation , Endothelium, Vascular/physiology , Intercellular Adhesion Molecule-1/pharmacology , Lymphocytes/drug effects , Cell Adhesion/drug effects , Cells, Cultured , Endothelium, Vascular/cytology , Humans , Intercellular Adhesion Molecule-1/blood , Lymphocytes/physiology , Monocytes/drug effects , Monocytes/physiology , Multiple Sclerosis/blood , Multiple Sclerosis/physiopathology , Recombinant Proteins , SolubilityABSTRACT
Matrix metalloproteinase-9 (MMP-9) and its specific inhibitor, tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), were analysed by enzyme-linked immunosorbent assay (ELISA) and by zymography in serum and cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS). In contrast to patients with inflammatory diseases, MMP-9 levels were not elevated in CSF of ALS patients. In serum, however, compared to healthy donors, MMP-9 was significantly (p = 0.0003) increased up to levels as high as those of viral meningoencephalitis (VM) or bacterial meningitis (BM) patients. MMP-9 levels remained elevated during long-term observation of ALS patients. In the absence of an inflammatory response, the results indicate that the increase of MMP-9 in serum of ALS patients might be caused by upregulation of MMP-9 in denervated muscles or in degenerating peripheral nerves following motor neurone loss.
Subject(s)
Matrix Metalloproteinase 9/blood , Motor Neuron Disease/blood , Adult , Aged , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Encephalitis, Viral/blood , Encephalitis, Viral/cerebrospinal fluid , Enzyme-Linked Immunosorbent Assay , Female , Guillain-Barre Syndrome/blood , Guillain-Barre Syndrome/cerebrospinal fluid , Humans , Male , Matrix Metalloproteinase 9/cerebrospinal fluid , Meningitis, Bacterial/blood , Meningitis, Bacterial/cerebrospinal fluid , Meningoencephalitis/blood , Meningoencephalitis/cerebrospinal fluid , Middle Aged , Motor Neuron Disease/cerebrospinal fluid , Motor Neuron Disease/enzymology , Multiple Sclerosis/blood , Multiple Sclerosis/cerebrospinal fluid , Multiple Sclerosis/enzymology , Reference Values , Tissue Inhibitor of Metalloproteinase-1/blood , Tissue Inhibitor of Metalloproteinase-1/cerebrospinal fluidABSTRACT
Multiple sclerosis lesions may occur predominantly in the hemispheric white matter and cause various psychiatric disorders such as remitting-relapsing endoform or exogenous psychosis, organic personality alterations and dementia. Nineteen patients suffering from this encephalitic form of multiple sclerosis as diagnosed by characteristic CSF immunoglobulin findings are analysed according to established psychopathological criteria. All cases began with psychiatric symptoms and neurological signs were either absent or overlooked. Several patients developed typical encephalomyelitic symptoms in successive relapses, but other remained with psychiatric disorders over many years. Only four patients had retrobulbar neuritis, but seven suffered from epileptic seizures. The humoral immune response was characterized by a strong dominance of IgG and a local synthesis of polyspecific antibodies against measles, rubella and varicella/zoster virus. The mononuclear CSF pleocytosis was comparatively marked with cell counts up to 180/microliter.